Travel
Sites
Visit
Goa, Karnataka,
Kerala,
Tamil
Nadu, Andhra
Pradesh
in South India,
Delhi,
Rajasthan,
Uttar
Pradesh, Himachal
Pradesh in North India, Assam,
Bengal,
Sikkim
in East India
|
|
|
|
Go
To Index
Page
Herbal extract for heart patients
Washington:
A herbal medicinal substance extracted from the
leaves of Crataegus tree has been found to be a natural
antioxidant and extends the life of heart failure
patients by 4 months. The researchers found the substance
called Crataegus Extract WS1442, safely extends the
lives of congestive heart failure patients already
receiving pharmacological treatment. The randomized,
double-blind trial, known as the SPICE study, was
conducted at 156 centers in Europe. The majority of
the patients were male (84 percent) and nearly half
the group (44 percent) were classified as NYHA III,
meaning they were significantly impaired by their
heart condition. The primary endpoint of the study
was time to first cardiac event, including sudden
cardiac death, death due to progressive heart failure,
fatal heart attack, non-fatal heart attack or hospitalization
due to heart failure. A total of 2,681 patients with
markedly impaired left ventricular function - indicating
advanced congestive heart failure - were randomized
to WS 1442 or placebo for a duration of two years.
All patients were already receiving pharmacological
therapy with ACE-inhibitors (83 percent), beta-blockers
(64 percent), glycosides (57 percent), spironolactone
(39 percent) and diuretics (85 percent). Dr. Christian
J. F. Holubarsch and his team saw a 20 percent reduction
in cardiac-related deaths among patients on the herbal
medicinal substance, and found that patients' lives
were extended by four months during the first 18 months
of the study. The safety of the compound was confirmed
by a lower number of adverse events among the study
group than those on placebo. "WS 1442 is safe in patients
with more severe congestive heart failure and left
ventricular ejection fraction lower than 35 percent.
It postpones death of cardiac cause after 18 months
and sudden cardiac death in an important subgroup
of patients," said Dr. Holubarsch of Median Kliniken
Hospitals in Bad Krozingen, Germany, and lead study
author. The study was presented at the American College
of Cardiology's 56th Annual Scientific Session.
- March 28, 2007
|
|
|
|